The Pew-MacArthur Results First Initiative in Idaho

This page was updated in July 2018 to note the conclusion of the state’s work with the Pew-MacArthur Results First Initiative.

Background

In February 2011, Idaho became the first state to partner with the Pew-MacArthur Results First Initiative. The Idaho Criminal Justice Commission, or ICJC, a 25-member body representing the three branches of Idaho state government, invited Results First to work with them to inform public policy decisions in criminal justice.

The commission was created in 2005 to address issues and challenges in the area of criminal justice through the development of balanced, cost-effective solutions based on best practices. It has made measurable progress in advancing evidence-based practices in criminal justice system. 

Implementation

Results First began to work with the ICJC in 2011 to incorporate adult criminal justice data into the model. In May 2014, the Idaho Results First team presented their analysis of the state’s adult criminal justice programs to the ICJC. 

Learn more about our state work.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.